Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996032 · ClinicalTrials.gov registry record
CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study
A clinical trial, sponsored by Boston Medical Center.
- Completed
- Registry status
- 187
- Enrollment target
NCT02996032: Completed study, sponsored by Boston Medical Center.
NCT02996032 is a clinical trial that has completed, run by Boston Medical Center. The registered enrollment target is 187 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02996032 has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- 187 participants
- Enrollment target
Study Summary
This is a study to determine if two ultrasound measures (Corrected Flow Time and B-Lines) can predict patients at higher risk of readmission within 30 days of hospital discharge for decompensated heart failure.
Primary Outcome
Daily corrected flow time measures will be obtained during hospitalization. Mean hospitalization time for the study population is 9 days, but will be measured during the duration of their hospitalization. Changes in corrected flow time values will be assessed for associations with 30 day return visits. 30 Day returns will be determined by medical record review as well as follow up phone calls to patients. Corrected Flow Time is a single measure performed serial with the same units of measure.
Interventions
- OTHER Vascular and Pulmonary Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 187 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-04 |
What the finished NCT02996032 record still lists
NCT02996032 is an observational study that tracks outcomes without assigning an intervention. The registered 187 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Vascular and Pulmonary Ultrasound is the first listed.
NCT02996032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02996032 about?
NCT02996032 is a clinical study titled "CRUSH STUDY: Calculating Readmission Risk by Ultrasound for Heart Failure Failure Study". This is a study to determine if two ultrasound measures (Corrected Flow Time and B-Lines) can predict patients at higher risk of readmission within 30 days of hospital discharge for decompensated heart failure.
What is the current status of trial NCT02996032?
This trial is currently completed. The enrollment target is 187 participants. The study started on 2016-11. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02996032?
The interventions under investigation include: Vascular and Pulmonary Ultrasound (OTHER).
Who is sponsoring clinical trial NCT02996032?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06153251 · 187 participants · Phase 1
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
- NCT06254898 · 187 participants · NA
Use of Incentives for Stressful Medical Procedures
- NCT07062237 · 187 participants · NA
A Randomized Clinical Trial Comparing Embryo Euploidy Rates Following Ultrashort Versus Standard Abstinence
- NCT07217574 · 187 participants
Program in Oncology for Tribal Health Systems.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia